Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital Plans to Commence Tender Offer to Repurchase up to $194 Million of Additional Shares

KROS

<p>同意回购 ADAR1 Capital Management 和 Pontifax Venture Capital 持有的所有股份，计划开始要约回购最多 1.94 亿美元的额外股份</p>

Keros Therapeutics 宣布计划返还 3.75 亿美元的过剩资本